IDEAS home Printed from https://ideas.repec.org/a/gam/jcltec/v2y2020i4p33-541d463055.html
   My bibliography  Save this article

Hydrogen Is Promising for Medical Applications

Author

Listed:
  • Shin-ichi Hirano

    (Department of Research and Development, MiZ Company Limited, 2-19-15 Ofuna, Kamakura, Kanagawa 247-0056, Japan)

  • Yusuke Ichikawa

    (Department of Research and Development, MiZ Company Limited, 2-19-15 Ofuna, Kamakura, Kanagawa 247-0056, Japan)

  • Bunpei Sato

    (Department of Research and Development, MiZ Company Limited, 2-19-15 Ofuna, Kamakura, Kanagawa 247-0056, Japan)

  • Fumitake Satoh

    (Department of Research and Development, MiZ Company Limited, 2-19-15 Ofuna, Kamakura, Kanagawa 247-0056, Japan)

  • Yoshiyasu Takefuji

    (Faculty of Environment and Information Studies, Keio University, 5322 Endo, Fujisawa 252-0882, Japan)

Abstract

Hydrogen (H 2 ) is promising as an energy source for the next generation. Medical applications using H 2 gas can be also considered as a clean and economical technology. Since the H 2 gas based on electrolysis of water production has potential to expand the medical applications, the technology has been developed in order to safely dilute it and to supply it to the living body by inhalation, respectively. H 2 is an inert molecule which can scavenge the highly active oxidants including hydroxyl radical (·OH) and peroxynitrite (ONOO − ), and which can convert them into water. H 2 is clean and causes no adverse effects in the body. The mechanism of H 2 is different from that of traditional drugs because it works on the root of many diseases. Since H 2 has extensive and various effects, it may be called a “wide spectrum molecule” on diseases. In this paper, we reviewed the current medical applications of H 2 including its initiation and development, and we also proposed its prospective medical applications. Due to its marked efficacy and no adverse effects, H 2 will be a next generation therapy candidate for medical applications.

Suggested Citation

  • Shin-ichi Hirano & Yusuke Ichikawa & Bunpei Sato & Fumitake Satoh & Yoshiyasu Takefuji, 2020. "Hydrogen Is Promising for Medical Applications," Clean Technol., MDPI, vol. 2(4), pages 1-13, December.
    • Handle: RePEc:gam:jcltec:v:2:y:2020:i:4:p:33-541:d:463055
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/2571-8797/2/4/33/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/2571-8797/2/4/33/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Till Strowig & Jorge Henao-Mejia & Eran Elinav & Richard Flavell, 2012. "Inflammasomes in health and disease," Nature, Nature, vol. 481(7381), pages 278-286, January.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Damien Guilbert & Gianpaolo Vitale, 2021. "Hydrogen as a Clean and Sustainable Energy Vector for Global Transition from Fossil-Based to Zero-Carbon," Clean Technol., MDPI, vol. 3(4), pages 1-29, December.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Demetrios Petrakis & Loukia Vassilopoulou & Charalampos Mamoulakis & Christos Psycharakis & Aliki Anifantaki & Stavros Sifakis & Anca Oana Docea & John Tsiaoussis & Antonios Makrigiannakis & Aristides, 2017. "Endocrine Disruptors Leading to Obesity and Related Diseases," IJERPH, MDPI, vol. 14(10), pages 1-18, October.
    2. Wendy N. Phoswa & Olive P. Khaliq & Simeon Eche, 2023. "A Review on Inflammasomes and Immune Checkpoints in Pre-Eclampsia Complicated with Tuberculosis and Human Immune Deficiency Virus," IJERPH, MDPI, vol. 20(17), pages 1-15, August.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jcltec:v:2:y:2020:i:4:p:33-541:d:463055. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.